ETC Baltimore Company Makes Major Advances in Artificial Intellegence for Drug Discovery

Artificial intelligence may streamline pharmaceutical R&D by predicting pharmacological properties of small molecules in silico Baltimore, MD (PRWEB) June 01, 2016 The ETC (Emerging Technology Centers) today announced major advances in deep learning for pharmaceutical R&D made by one of their member companies located at its ETC Eastern Campus since February 2014. In the course of one week, the company announced the publication of two papers demonstrating proof of concept of applications of deep neural networks to drug discovery and repurposing in “Deep learning applications for predicting pharmacological properties of drugs and drug repurposing using transcriptomic data” in Molecular Pharmaceutics, one of the influential American Chemical Society journals, and biomarker development in “Deep biomarkers of human aging: Application of deep neural networks to biomarker development” in Aging, one of the…


Link to Full Article: ETC Baltimore Company Makes Major Advances in Artificial Intellegence for Drug Discovery